Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ENTADFI safely and effectively. See full prescribing information for ENTADFI. ENTADFI™ (finasteride and tadalafil) capsules, for oral useInitial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
ENTADFI is indicated to initiate treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate for up to 26 weeks. Limitations of Use ENTADFI is not recommended for more than 26 weeks because the incremental benefit of tadalafil decreases from 4 weeks until 26 weeks, and the incremental benefit beyond 26 weeks is unknown [see Clinical Studies (14)].
- generic_name
- finasteride and tadalafil
- product_names
- finasteride and tadalafil
- ndc
- 69681-125, 69681-125-30, 69681-125-90
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en